These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25375916)

  • 1. Lrp5 regulation of bone mass and serotonin synthesis in the gut.
    Kode A; Obri A; Paone R; Kousteni S; Ducy P; Karsenty G
    Nat Med; 2014 Nov; 20(11):1228-9. PubMed ID: 25375916
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Lrp5 regulation of bone mass and gut serotonin synthesis.
    Cui Y; Niziolek PJ; MacDonald BT; Alenina N; Matthes S; Jacobsen CM; Conlon RA; Brommage R; Powell DR; He X; Bader M; Williams BO; Warman ML; Robling AG
    Nat Med; 2014 Nov; 20(11):1229-30. PubMed ID: 25375917
    [No Abstract]   [Full Text] [Related]  

  • 3. Lrp5 functions in bone to regulate bone mass.
    Cui Y; Niziolek PJ; MacDonald BT; Zylstra CR; Alenina N; Robinson DR; Zhong Z; Matthes S; Jacobsen CM; Conlon RA; Brommage R; Liu Q; Mseeh F; Powell DR; Yang QM; Zambrowicz B; Gerrits H; Gossen JA; He X; Bader M; Williams BO; Warman ML; Robling AG
    Nat Med; 2011 Jun; 17(6):684-91. PubMed ID: 21602802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin.
    Frost M; Andersen TE; Yadav V; Brixen K; Karsenty G; Kassem M
    J Bone Miner Res; 2010 Mar; 25(3):673-5. PubMed ID: 20200960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes.
    Balemans W; Van Hul W
    Endocrinology; 2007 Jun; 148(6):2622-9. PubMed ID: 17395706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of bone metabolism by pathogenic mutations and polymorphism in the LRP5-Wnt signaling genes].
    Urano T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():95-100. PubMed ID: 18161089
    [No Abstract]   [Full Text] [Related]  

  • 8. Lrp5 and bone formation : A serotonin-dependent pathway.
    Yadav VK; Ducy P
    Ann N Y Acad Sci; 2010 Mar; 1192():103-9. PubMed ID: 20392224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The holy grail of high bone mass.
    Bonewald L
    Nat Med; 2011 Jun; 17(6):657-8. PubMed ID: 21647140
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytokines in bone diseases. Wnt signaling and osteoporosis-pseudoglioma syndrome].
    Ozono K
    Clin Calcium; 2010 Oct; 20(10):1520-5. PubMed ID: 20890034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass.
    Ferrari SL; Deutsch S; Antonarakis SE
    Curr Opin Lipidol; 2005 Apr; 16(2):207-14. PubMed ID: 15767861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
    Gong Y; Slee RB; Fukai N; Rawadi G; Roman-Roman S; Reginato AM; Wang H; Cundy T; Glorieux FH; Lev D; Zacharin M; Oexle K; Marcelino J; Suwairi W; Heeger S; Sabatakos G; Apte S; Adkins WN; Allgrove J; Arslan-Kirchner M; Batch JA; Beighton P; Black GC; Boles RG; Boon LM; Borrone C; Brunner HG; Carle GF; Dallapiccola B; De Paepe A; Floege B; Halfhide ML; Hall B; Hennekam RC; Hirose T; Jans A; Jüppner H; Kim CA; Keppler-Noreuil K; Kohlschuetter A; LaCombe D; Lambert M; Lemyre E; Letteboer T; Peltonen L; Ramesar RS; Romanengo M; Somer H; Steichen-Gersdorf E; Steinmann B; Sullivan B; Superti-Furga A; Swoboda W; van den Boogaard MJ; Van Hul W; Vikkula M; Votruba M; Zabel B; Garcia T; Baron R; Olsen BR; Warman ML;
    Cell; 2001 Nov; 107(4):513-23. PubMed ID: 11719191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites.
    Ferrari SL; Deutsch S; Choudhury U; Chevalley T; Bonjour JP; Dermitzakis ET; Rizzoli R; Antonarakis SE
    Am J Hum Genet; 2004 May; 74(5):866-75. PubMed ID: 15077203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.
    Yadav VK; Ryu JH; Suda N; Tanaka KF; Gingrich JA; Schütz G; Glorieux FH; Chiang CY; Zajac JD; Insogna KL; Mann JJ; Hen R; Ducy P; Karsenty G
    Cell; 2008 Nov; 135(5):825-37. PubMed ID: 19041748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intestinal serotonin and regulation of bone mass].
    Oury F; Karsenty G
    Med Sci (Paris); 2009 May; 25(5):445-6. PubMed ID: 19480820
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-density lipoprotein receptor-related protein 5 (LRP5) gene polymorphisms are associated with bone mass in both Chinese and whites.
    Xiong DH; Lei SF; Yang F; Wang L; Peng YM; Wang W; Recker RR; Deng HW
    J Bone Miner Res; 2007 Mar; 22(3):385-93. PubMed ID: 17241106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender specific LRP5 influences on trabecular bone structure and strength.
    Dubrow SA; Hruby PM; Akhter MP
    J Musculoskelet Neuronal Interact; 2007; 7(2):166-73. PubMed ID: 17627087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
    Levasseur R; Lacombe D; de Vernejoul MC
    Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men.
    Kiel DP; Ferrari SL; Cupples LA; Karasik D; Manen D; Imamovic A; Herbert AG; Dupuis J
    Bone; 2007 Mar; 40(3):587-96. PubMed ID: 17137849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokines in bone diseases. Wnt signal and excessive bone formation].
    Hosoi T
    Clin Calcium; 2010 Oct; 20(10):1526-31. PubMed ID: 20890035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.